Cargando…
Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure
BACKGROUND: This study aimed to investigate the clinical utility of different soluble suppression of tumorigenicity 2 (sST2) levels in assessing the severity and prognosis of patients with acute heart failure (AHF). METHODS: This was a prospective cohort study. Three hundred and thirty-one consecuti...
Autores principales: | Wang, Zeyu, Pan, Xin, Xu, Hong, Wu, You, Jia, Xiaomin, Fang, Yiling, Lu, Yi, Xu, Yawei, Zhang, Ji, Su, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863653/ https://www.ncbi.nlm.nih.gov/pubmed/35224046 http://dx.doi.org/10.3389/fcvm.2022.812654 |
Ejemplares similares
-
The Diagnostic Value of Soluble ST2 in Heart Failure: A Meta-Analysis
por: Yang, Chaojun, et al.
Publicado: (2021) -
Prognostic Value of Serum Galectin-3 in Chronic Heart Failure: A Meta-Analysis
por: Cheng, Zhendong, et al.
Publicado: (2022) -
Diagnostic and prognostic value of serum soluble suppression of tumorigenicity-2 in heart failure with preserved ejection fraction: A systematic review and meta-analysis
por: Shi, Yujiao, et al.
Publicado: (2022) -
Association Between Arterial Stiffness and Heart Failure With Preserved Ejection Fraction
por: Chi, Chen, et al.
Publicado: (2021) -
Soluble ST2 in coronary artery disease: Clinical biomarkers and treatment guidance
por: Zhang, Junyan, et al.
Publicado: (2022)